Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Probiotics, to Provide a Legitimate Reason for the Administration of Probiotic Therapy in the Hospitalized Patient, Particularly in Patients on Antibiotic Therapy

NCT00506181 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00506181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00506181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Probiotics, to Provide a Legitimate Reason for the Administration of Probiotic Therapy in the Hospitalized Patient, Particularly in Patients on Antibiotic Therapy
Lead sponsor
Hadassah Medical Organization
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2007
Completion date
July 31, 2008
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, diarrhea